Severe Hypercalcemia During Lactation in a Patient With Pre-existing Hypoparathyroidism.
Careful monitoring of calcium levels is crucial for hypoparathyroid patients during pregnancy and lactation to prevent hypercalcemia.
Where it sits
this study against the rest of the abaloparatide (tymlos) corpusSummary and findings
A 35-year-old woman with post-operative hypoparathyroidism experienced severe hypercalcemia during lactation after two pregnancies. Adjusting her calcium and calcitriol supplementation normalized her calcium levels. This case underscores the need for careful monitoring of calcium levels in hypoparathyroid patients during pregnancy and lactation.
Abstract
Calcium homeostasis undergoes significant physiologic changes during pregnancy and lactation to support fetal skeletal development and neonatal calcium needs. During pregnancy, calcium requirements are met by increased activation of 1,25-dihydroxyvitamin D (1,25-(OH)<sub>2</sub>D) by placental 1a-hydroxylase and by increased maternal and placental secretion of parathyroid hormone-related protein (PTHrP). Conversely, during lactation, calcium demand is met by maternal bone resorption driven by postpartum decline in estrogen levels and by PTHrP produced by maternal breast tissue. These physiologic adaptations complicate the management of patients with primary hypoparathyroidism, who require calcium and calcitriol supplementation to maintain eucalcemia. Herein, we describe a case of a 35-year-old woman with post-operative hypoparathyroidism following total thyroidectomy for metastatic papillary thyroid carcinoma who developed hypercalcemia during lactation after each of her two pregnancies. Reducing her calcium and calcitriol supplementation rapidly normalized her calcium levels. This case highlights how physiologic changes in calcium metabolism during pregnancy and lactation can significantly alter calcium and calcitriol requirements in patients with hypoparathyroidism. Continuation of prepartum calcium and calcitriol regimens during pregnancy and lactation can cause maternal hypercalcemia. Thus, close surveillance of calcium levels in women with hypoparathyroidism is essential to adjust calcium and calcitriol supplementation and avoid hypercalcemia.
Background
Calcium homeostasis is crucial during pregnancy and lactation due to increased demands for fetal and neonatal development. Patients with hypoparathyroidism, who rely on calcium and calcitriol supplementation, face unique challenges during these periods. This study explores the impact of these physiological changes on calcium management in such patients.
Methods
This is a case report of a 35-year-old woman with post-operative hypoparathyroidism following thyroidectomy. The study describes her experience of hypercalcemia during lactation after two pregnancies and the subsequent management adjustments.
Results
The patient developed severe hypercalcemia during lactation, which was resolved by reducing her calcium and calcitriol supplementation. This adjustment normalized her calcium levels, highlighting the need for tailored supplementation during lactation in hypoparathyroid patients.
Interpretation
The case emphasizes the importance of monitoring and adjusting calcium and calcitriol supplementation in hypoparathyroid patients during pregnancy and lactation. While the findings are consistent with known physiological changes, the clinical significance is limited by the single-patient context.
Key findings
- Severe hypercalcemia during lactation in a patient with hypoparathyroidism.
- Normalization of calcium levels by reducing calcium and calcitriol supplementation.
- Case involved a 35-year-old woman with post-operative hypoparathyroidism.
Limitations
- Single case report
- Specific to post-operative hypoparathyroidism
- No control group
- Findings not generalizable